New MOAB-2 based Aβ Oligomeric ELISA kit

March 3, 2014

A new and highly specific monoclonal antibody based ELISA for the detection of oligomeric Aβ42 in CSF, cell supernatants, and tissue extracts

ADELAIDE, AUSTRALIA - Mar 4, 2014 - Biosensis is proud to announce the release of its exclusive Oligomeric Amyloid beta (oAβ) ELISA built upon the anti-amyloid beta monoclonal MOAB-2.

Aβ Oligomeric ELISA kit (Catalog No: BEK-2215-2P)

This is the first oligomeric amyloid beta ELISA to take advantage of MOAB-2's high specificity and avidity for beta amyloid peptides.
Biosensis' oligomeric amyloid beta ELISA kit allows for the detection of amyloid beta oligomers and complexes present in mouse and human CSF and brain tissue extracts.
Great dynamic range!
Superb low end sensitivity!
Validated by Literature!

Coming soon: MOAB-2 based Aβ/APOE & Aβ/APOJ complex ELISAs ONLY from Biosensis.

Seewww.biosensis.comfor more details.